Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model
Crossref DOI link: https://doi.org/10.1007/s40268-016-0163-7
Published Online: 2017-01-11
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brunelli, Steven M.
Sibbel, Scott P.
Van Wyck, David
Sharma, Amit
Hsieh, Andrew
Chertow, Glenn M.
Funding for this research was provided by:
Keryx Biopharmaceuticals, Inc.
License valid from 2017-01-11